Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension
Download in electronic PDF format for $65
Abstract: A formulation for preparing Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords:
Loyd V. Allen, Jr, PhD, RPh, quetiapine fumarate, antipsychotic agent, formulation, schizophrenia, psychotic disorders, bipolar disorder
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 342
|
Quetiapine Fumarate 10 mg/mL in Ora-Blend
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 506
|
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 449-450
|
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 310-312
|
Prednisolone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2020
Pg. 229
|
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 487
|
Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 46-48
|
Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 417
|
Methylprednisolone 4-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 340
|
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
|
May/Jun 2010
Pg. 182-192
|
